These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21424450)

  • 1. Hydrogel templates for the fabrication of homogeneous polymer microparticles.
    Acharya G; McDermott M; Shin SJ; Park H; Park K
    Methods Mol Biol; 2011; 726():179-85. PubMed ID: 21424450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hydrogel template method for fabrication of homogeneous nano/microparticles.
    Acharya G; Shin CS; McDermott M; Mishra H; Park H; Kwon IC; Park K
    J Control Release; 2010 Feb; 141(3):314-9. PubMed ID: 19822178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The administration of BDNF and GDNF to the brain via PLGA microparticles patterned within a degradable PEG-based hydrogel: Protein distribution and the glial response.
    Lampe KJ; Kern DS; Mahoney MJ; Bjugstad KB
    J Biomed Mater Res A; 2011 Mar; 96(3):595-607. PubMed ID: 21254391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of drug release from homogeneous PLGA microstructures.
    Acharya G; Shin CS; Vedantham K; McDermott M; Rish T; Hansen K; Fu Y; Park K
    J Control Release; 2010 Sep; 146(2):201-6. PubMed ID: 20381555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles.
    Zhao A; Rodgers VG
    J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum.
    Kohane DS; Tse JY; Yeo Y; Padera R; Shubina M; Langer R
    J Biomed Mater Res A; 2006 May; 77(2):351-61. PubMed ID: 16425240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pore size distributions of biodegradable polymer microparticles in aqueous environments measured by NMR cryoporometry.
    Petrov O; Furó I; Schuleit M; Domanig R; Plunkett M; Daicic J
    Int J Pharm; 2006 Feb; 309(1-2):157-62. PubMed ID: 16386391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision synthesis of biodegradable polymers.
    Thomas CM; Lutz JF
    Angew Chem Int Ed Engl; 2011 Sep; 50(40):9244-6. PubMed ID: 21793138
    [No Abstract]   [Full Text] [Related]  

  • 10. Tuning the formation and degradation of layer-by-layer assembled polymer hydrogel microcapsules.
    Becker AL; Zelikin AN; Johnston AP; Caruso F
    Langmuir; 2009 Dec; 25(24):14079-85. PubMed ID: 20560555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin.
    Kim M; Jung B; Park JH
    Biomaterials; 2012 Jan; 33(2):668-78. PubMed ID: 22000788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio.
    Klose D; Siepmann F; Willart JF; Descamps M; Siepmann J
    Int J Pharm; 2010 Jan; 383(1-2):123-31. PubMed ID: 19748558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained local drug delivery from a novel polymeric ring to inhibit intimal hyperplasia.
    Kanjickal D; Lopina S; Evancho-Chapman MM; Schmidt S; Donovan D
    J Biomed Mater Res A; 2010 May; 93(2):656-65. PubMed ID: 19610053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation factors affecting the properties of polylactide nanoparticles: a factorial design study.
    Vandervoort J; Ludwig A
    Pharmazie; 2001 Jun; 56(6):484-8. PubMed ID: 11446170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
    Klose D; Siepmann F; Elkharraz K; Siepmann J
    Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.
    Kim DH; Martin DC
    Biomaterials; 2006 May; 27(15):3031-7. PubMed ID: 16443270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
    Díez S; Tros de Ilarduya C
    Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ micro-sized gel-forming injectable implant using biodegradable amphiphilic graft copolymer.
    Cho KY; Lee S; Park JK
    Macromol Biosci; 2007 Jun; 7(6):784-8. PubMed ID: 17541923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease.
    Yue IC; Poff J; Cortés ME; Sinisterra RD; Faris CB; Hildgen P; Langer R; Shastri VP
    Biomaterials; 2004 Aug; 25(17):3743-50. PubMed ID: 15020150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.